-+ 0.00%
-+ 0.00%
-+ 0.00%

ACURX PHARMACEUTICALS ANNOUNCES FIRST PATIENT ENROLLED IN PATHFINDER CLINICAL TRIAL OF IBEZAPOLSTAT IN MULTIPLY-RECURRENT C. DIFFICILE INFECTION

Reuters·09/29/2026 12:03:47